Aberrant claudin-6-adhesion signal promotes endometrial cancer progression via estrogen receptor α
M. Kojima, K. Sugimoto, M. Tanaka, Y. Endo, N. Ichikawa-Tomikawa, K. Kashiwagi, H. Kato, T. Honda, S. Furukawa, H. Nishiyama, T. Watanabe, S. Soeda, K. Fujimori, H. Chiba
The paper shows that CLDN6 promotes endometrial cancer progression by activating estrogen receptor α through SFK/PI3K signaling, independent of ligand.
bioRxiv · May 15, 2020 · PreprintCancer Biology